Hmm. Is this good news or not?
The FDA (Food and Drug Administration) has just approved aducanumab (Aduhelm) for Alzheimer’s. Of course, if you are Biogen, this is great news. But, since the data is – how do I say this?- less than emphatic- will this really help patients?